Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADSVF for Scarred Vocal Folds
NCT05385159Phase 2Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Sep 2022
- Primary completion
- Jun 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived stromal vascular fraction in vocal fold scarring, sponsored by Assistance Publique-Hôpitaux de Marseille. Status: unknown.
02
Drugs
autologous adipose-derived stromal vascular fraction
03
Conditions
vocal fold scarring
Beyond the preview
Go deeper on NCT05385159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05385159.